COMMUNIQUÉS West-GlobeNewswire

-
Enterome presents positive Phase 1/2 MSS/pMMR metastatic colorectal cancer data in patients treated with EO4010 OncoMimics™ immunotherapy plus nivolumab at ASCO 2025
30/05/2025 -
Le Québec a les cartes en main pour réduire les impacts des écrans sur la santé des jeunes
30/05/2025 -
Communiqué de presse : L’itépekimab a satisfait au critère d’évaluation principal dans l’une des deux études de phase 3 sur la BPCO
30/05/2025 -
Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies
30/05/2025 -
Roche’s fenebrutinib maintains near-complete suppression of disease activity and disability progression for up to two years in people with relapsing multiple sclerosis
30/05/2025 -
Itepekimab Met Primary Endpoint in One of Two Chronic Obstructive Pulmonary Disease (COPD) Phase 3 Trials
30/05/2025 -
Arcutis to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
29/05/2025 -
Cytokinetics to Participate in the Jefferies Global Healthcare Conference
29/05/2025 -
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
29/05/2025 -
Gyre Therapeutics Announces Closing of its Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
29/05/2025 -
Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) For Extended-Release Oral Suspension at SLEEP 2025
29/05/2025 -
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
29/05/2025 -
Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences
29/05/2025 -
Annexon Biosciences to Present at the Jefferies Global Healthcare Conference
29/05/2025 -
Amneal to Participate at Upcoming Investor Conferences in June
29/05/2025 -
NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025
29/05/2025 -
Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025
29/05/2025 -
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June
29/05/2025 -
Fulcrum Therapeutics to Present at Upcoming Medical Meetings
29/05/2025
Pages